REGENXBIO, Inc. (RGNX)
5.62
-0.03
(-0.53%)
USD |
NASDAQ |
May 19, 15:32
REGENXBIO EPS Diluted (TTM) : -5.59 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | -0.9641 |
| Ocugen, Inc. | -0.2318 |
| Replimune Group, Inc. | -3.582 |
| AbbVie, Inc. | 2.027 |
| Krystal Biotech, Inc. | 7.482 |